Dr James Price

James Price graduated from the University of Sheffield in 2009. He gained MRCP (UK) in 2012 and was appointed as a registrar in Clinical Oncology in the East Midlands in 2013. Having attained the FRCR (2017) and completed specialty training, James completed a post-CCT Clinical Fellowship in Proton Beam Therapy at The Christie NHS Foundation Trust in 2020. In 2020 he was appointed as the inaugural Taylor Family Foundation PhD Research Fellow at The University of Manchester and Consultant Oncologist at The Christie. James is the clinical lead for the rollout of electronic patient-reported outcome measures (ePROMs) at The Christie and quality assurance lead for the UK Phase III TORPEdO trial (TOxicity Reduction using Proton bEam therapy for oropharyngeal cancer).